Alpha Tau Medical (DRTS) Non-Current Deferred Tax Liability (2025 - 2026)
Alpha Tau Medical's (DRTS) quarterly Non-Current Deferred Tax Liability came in at $85000.0 in Q1 2026, down 12.37% quarter-over-quarter from $97000.0 in Q4 2025.
Alpha Tau Medical (DRTS) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed Non-Current Deferred Tax Liability across 2 years of filings, most recently posting $85000.0 for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $85000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $85000.0 (changed N/A YoY), and the FY2025 annual result was $97000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability came in at $85000.0 for Q1 2026 at Alpha Tau Medical, down from $97000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $160000.0 in Q2 2025 to a low of $85000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85,000.00 |
| Mar 31, 2026 | 85,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |